Skip to main content
PMC home page
Neuropsychopharmacology logoLink to Neuropsychopharmacology
. 2017 Aug 16;43(2):285–293. doi: 10.1038/npp.2017.134

A Key Role for Neurotensin in Chronic-Stress-Induced Anxiety-Like Behavior in Rats

Catherine P Normandeau 1,2, Ana Paula Ventura-Silva 3,4, Emily R Hawken 1,2, Staci Angelis 1,2, Calvin Sjaarda 5, Xudong Liu 5, José Miguel Pêgo 3,4, É C Dumont 1,2,*
PMCID: PMC5729557  PMID: 28649992

Abstract

Chronic stress is a major cause of anxiety disorders that can be reliably modeled preclinically, providing insight into alternative therapeutic targets for this mental health illness. Neuropeptides have been targeted in the past to no avail possibly due to our lack of understanding of their role in pathological models. In this study we use a rat model of chronic stress-induced anxiety-like behaviors and hypothesized that neuropeptidergic modulation of synaptic transmission would be altered in the bed nucleus of the stria terminalis (BNST), a brain region suspected to contribute to anxiety disorders. We use brain slice neurophysiology and behavioral pharmacology to compare the role of locally released endogenous neuropeptides on synaptic transmission in the oval (ov) BNST of non-stressed (NS) or chronic unpredictably stressed (CUS) rats. We found that in NS rats, post-synaptic depolarization induced the release of vesicular neurotensin (NT) and corticotropin-releasing factor (CRF) that co-acted to increase ovBNST inhibitory synaptic transmission in 59% of recorded neurons. CUS bolstered this potentiation (100% of recorded neurons) through an enhanced contribution of NT over CRF. In contrast, locally released opioid neuropeptides decreased ovBNST excitatory synaptic transmission in all recorded neurons, regardless of stress. Consistent with CUS-induced enhanced modulatory effects of NT, blockade of ovBNST NT receptors completely abolished stress-induced anxiety-like behaviors in the elevated plus maze paradigm. The role of NT has been largely unexplored in stress and our findings highlight its potential contribution to an important behavioral consequence of chronic stress, that is, exaggerated avoidance of open space in rats.

Introduction

While the stress response is integral for survival, prolonged exposure to stressors can have damaging consequences. Repeated exposure to aversive stressors predicts and contributes to mental illnesses such as generalized anxiety disorders, major depressive disorder, or post-traumatic stress disorder (Deppermann et al, 2014; Gosselin and Laberge, 2003; Hammen et al, 2009). However, the biochemical imbalances caused by repeated stress in the brain remain elusive and animal models of chronic stress are essential to elucidate these mechanisms (Conrad et al, 2011).

Repeated aversive stressors result in increased volume and dendritic branching as well as long-term alterations of excitatory synaptic transmission in the bed nucleus of the stria terminalis (BNST) (Conrad et al, 2011; Dabrowska et al, 2013; Glangetas et al, 2013; Hubert and Muly, 2014; McElligott et al, 2010; Pego et al, 2008; Vyas et al, 2003). Surprisingly, the effects of chronic stress on local γ-aminobutyric acid (GABA) transmission, imperative for fine-tuning neuronal output, have been largely unexplored in the BNST. Neuropeptides are potent modulators of GABA transmission in the BNST, but whether their function is altered in chronically stressed rats has never been investigated (Crowley et al, 2016; Kash and Winder, 2006; Krawczyk et al, 2013). Neuropeptides in the BNST may be affected by chronic stress due to their involvement in the modulation of stress- or aversion-related phenomena (Lezak et al, 2014; Walker et al, 2009).

Specifically, the oval nucleus of the BNST (ovBNST) contains high concentrations of many different neuropeptides and activation of this specific nucleus increases anxiety-like behaviors suggesting it may be sensitive to chronic stress (Kim et al, 2013). Therefore, we hypothesized that chronic stress would change neuropeptide modulation of synaptic transmission in the ovBNST. We used the chronic unpredictable stress (CUS) paradigm to test this hypothesis, a preclinical model that mimics everyday stressors and invariably increases anxiety-like behaviors in rats (Cerqueira et al, 2007). Interestingly, the neuromodulatory effects of neurotensin (NT), but not of corticotropin-releasing factor (CRF), became sensitized after 1-month exposure to CUS. Accordingly, in vivo pharmacological blockade of ovBNST NT receptors (NTRs) had an anxiolytic effect in CUS rats. The neuropeptide NT is therefore a significant contributor to ovBNST promotion of anxiety-like behavior in chronically stressed animals.

Materials and methods

Rats

A total of 133 adult male rats (Charles River Laboratories, Canada/Spain) weighing 350–450 g were included in the electrophysiology experiments (Wistar and Long Evans rats, n=63) and behavioral experiments (Wistar rats, n=70). The rats were maintained on an artificial 12 h light/dark cycle (0800 hours lights on/2000 hours lights off) or 12 h dark/light cycle (0800 hours lights off/2000 hours lights on).

The rats acclimatized for a minimum of 1 week upon arrival to the facility. Rat chow and water were provided ad libitum in the home cages. In all, 63 rats were used for electrophysiology (Canada), 33 rats performed the elevated plus maze (EPM; Portugal), and 37 rats performed the EPM and the forced swim test (FST; Canada). All experiments were conducted in accordance with the guidelines from the Canadian Council on Animal Care in Science and approved by the Queen’s University Animal Care Committee and with Portugal local regulations (European Union Directive 86/609/EEC).

Slice Preparation and Electrophysiology

Rats were anesthetized with isoflurane (5% at 5 l/min) and their brains removed into ice-cold artificial cerebral spinal fluid (aCSF) containing (in mM): 126 NaCl; 2.5 KCl; 1.2 MgCl2; 6 CaCl2; 1.2 NaH2PO4; 25 NaHCO3; and 12.5 D-glucose equilibrated with 95% O2/5% CO2. Brains were cut in 2 °C aCSF into coronal slices (250 μm) with a vibrating blade microtome (VT-1000; Leica). We used the slice corresponding to −0.26 mm from bregma. Slices were incubated at 34 °C for 60 min and transferred to a chamber perfused (3 ml/min) with aCSF at 34 °C. Remaining slices were kept in aCSF at room temperature until further use. Whole-cell voltage-clamp recordings were made using glass microelectrodes (3–5 MΩ) filled with (in mM): 70 K+-gluconate; 80 KCl; 1 EGTA; 5 HEPES; 2 MgATP; 0.3 GTP; and 1 P-creatine. We recorded lateral from an imaginary line drawn vertically across the lateral ventricle and medial to the internal capsule. In the dorso-ventral plan, we only recorded dorsally to an imaginary horizontal line drawn halfway between the ventral tip of the lateral ventricle and the top of the anterior commissure as illustrated in our previous publications (Krawczyk et al, 2011a; Krawczyk et al, 2011b). Paired electrical stimuli (10–100 μA, 0.1 ms duration, 20 Hz) were applied at 0.1 Hz. Excitatory or inhibitory post-synaptic currents (E/IPSCs) were evoked by local fiber stimulation with tungsten bipolar electrodes while neurons were voltage-clamped at −70 mV. GABAA-IPSC and AMPA-EPSC were pharmacologically isolated with 6,7-dinitroquinoxaline-2,3-dione (DNQX; 50 μM) or picrotoxin (100 μM), respectively. To induce local endogenous neuropeptide release, post-synaptic neurons were repetitively depolarized in voltage clamp from −70 to 0 mV (100 ms) at a frequency of 2 Hz for 5 min (Iremonger and Bains, 2009).

We defined long-lasting post-synaptic depolarization-induced changes in E or IPSC peak amplitude as a >20% deviation from baseline, 25 min following the end of the repetitive depolarization protocol. Recordings were made using a Multiclamp 700B amplifier and a Digidata 1440A (Molecular Devices Scientific). Data were acquired and analyzed with Axograph X running on Apple computers.

Drugs

Stock solutions of SR 142948 (10 mM) and naloxone (Nal; 1 mM) were prepared in double-distilled water, and stock solutions of DNQX (100 mM), NBI-27914 (50 mM), and concanamycin A (1 mM) were prepared in DMSO (100%). All drugs were further dissolved in the physiological solutions or 0.9% saline at the desired concentrations (DNQX 50 μM, SR-142948 5–10 μM, NBI-27914 1 μM, concanamycin A 5 μM, and Nal 1 μM) and the final DMSO concentration never exceeded 0.1%. Drugs were obtained from Sigma-Aldrich or R&D Systems.

Chronic Unpredictable Stress

Rats were singly housed and randomly assigned to non-stressed (NS) or CUS groups. Rats in the NS group were handled regularly over 4 weeks. Rats in the CUS group were exposed to 4 weeks of daily exposure to one stressor (10–60 min/day) at different times, as described previously (Cerqueira et al, 2007). Stressors presentation was randomized and included one of the following aversive stimuli: cold water immersion (18 °C, 60 min), home cage shaking (10 min), restraining (60 min), overcrowding (3–4 rats/cage, 60 min), and exposure to hot air stream (15 min).

Surgery

Rats were positioned in a stereotaxic instrument and secured by non-rupture ear bars under isoflurane (2–3%, 5 l/min) or ketamine/medetomidine anesthesia. Double-guide cannulas (Plastics One) were bilaterally implanted 1 mm above the upper limit of the oval region of the dorsal BNST (dBNST; −0.26 AP, ±1.9 ML, and −6.5 DV). Injector cannulas (Plastics One) were placed into the guide cannulas (7.5 mm length). All stereotaxic coordinates were relative to bregma. The head attachment was secured in place via four 0.08 × 0.125 in jeweler screws and dental acrylic cement. The guide cannulas were fitted with an autoclaved 30 Ga stylet and covered with a screw-on dust cap. Following surgery, the rats recovered for 1 week and then were randomly assigned to six experimental groups: NS (saline, n=11); NS SR 5 (SR-142948 5 μM, n=8); NS SR 10 (SR-142948 10 μM, n=6); CUS saline (saline, n=16); CUS SR 5 (SR-142948 5 μM, n=12); and CUS SR 10 (SR 142948 10 μM, n=17). Three rats (two in the NS SR5 group and one in the NS SR 10 group) were killed before the FST due to health issues.

Behavioral Tests

The rats were placed in the NS groups or the CUS groups receiving a 300 nl injection of either saline, SR-142948 5 μM, or SR-142948 10 μM 30 min before testing (Binder et al, 2001). Behavioral testing was done on 3 consecutive days, starting with the EPM followed by the FST.

Elevated Plus Maze

Rats were tested for 5 min in the EPM using a black polypropylene ‘plus’-shaped maze (Med Associates) as previously described (Pego et al, 2008). The maze consisted of two facing open arms (50.8 × 10.2 cm) and two closed arms (50.8 × 10.2 × 40.6 cm), 72 cm above the floor. Testing was performed under bright white light (≅40 lux). The time spent in the open arms, junction area, and closed arms, as well as the number of entrances and explorations in each section were recorded using a system of infrared photo beams, the crossings of which were monitored by a computer. The times spent in each of the compartments of the EPM are presented as percentage of the total duration of the trial.

Forced Swim Test

Rats were introduced to a cylindrical container filled with 30 cm of water (23–25 °C) for 15 min during pretest and 5 min during testing. The rats’ behavior was categorized as (1) immobile, (2) swimming, and (3) climbing (included diving). We defined immobile as the absence of directed movements, climbing as vertical movement of the forepaws and swimming as horizontal movement in the swim chamber. The predominant behavior over each 5 s period of the 300 s test was rated over a total score of 60 by an experimenter blind to the pharmacological treatment or the stress group.

Open Field

Animals were individually tested for 5 min each in an open field (OF) arena (43.2 × 43.2 cm) that had transparent acrylic walls and a white floor (model ENV-515, MedAssociates, St Albans, VT 05478). Each subject was initially placed in the center of the arena and horizontal activity and instant position were registered, using a system of two 16-beam infrared arrays connected to a computer. Total distances were used as indicators of locomotor activity.

Histological Procedures

Following behavioral testing, the rats were anesthetized with pentobarbital or isoflurane. Extracted brains were submerged in fresh paraformaldehyde for 2 days and switched to 30% sucrose paraformaldehyde for cryoprotection. The brains were kept at −80 °C until histology. The 30 μm coronal sections were sliced and stained with cresyl violet to assess the location of the central injections (Figure 5b and c).

RNA Extraction and Reverse Transcription

Brain sections containing the dBNST or the central amygdale (CeA) (Supplementary Figure S1) were collected from RNAlater (ThermoFisher Scientific) solution with a sterile tissue puncher and submerged in 100 μl of lysis/binding buffer from the Dynabeads mRNA Direct Micro Kit (ThermoFisher Scientific). The tissue was immediately homogenized in microcentrifuge tubes using a disposable pestle (Fisherbrand). mRNA was purified using the Dynabeads mRNA Direct Micro Kit (ThermoFisher Scientific) following the manufacturer’s recommended protocol for mRNA isolation from tissues. mRNA concentration was determined using the Qubit Fluorometer 2.0 (ThermoFisher Scientific). A unit of 40 ng of mRNA from each sample was reverse transcribed using the SuperScript IV First-Strand Synthesis kit (Invitrogen) in an Applied Biosystems GeneAmp PCR System 9700 (ThermoFisher Scientific).

Real-Time qPCR and Data Analysis

The cDNA was amplified in the ViiA7 Real-Time PCR machine (ThermoFisher Scientific) with a two-step PCR protocol (95 °C for 10 min followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min) using the Power SYBR Green PCR Master Mix (ThermoFisher Scientific) and KiCqStart SYBR Green Primers (Sigma-Aldrich) (Supplementary Table S1). Each reaction was performed in triplicate and dissociation curves were generated for all reactions to ensure primer specificity. All target genes were normalized to three reference genes (Sdha, Actb, and Hprt) and the relative quantification using the comparative Ct method was determined using the DataAssist Software Version 3.01 (ThermoFisher Scientific).

Statistical Analyses

Changes in E/IPSC peak amplitude were measured from baseline and are shown as percentages as follows: (peak amplitudepost−peak amplitudebaseline/peak amplitudebaseline) × 100. Data are reported as means±SEM and each data point represents the average of values in 1 min bins (six evoked E/IPSCs) across recorded neurons.

Two-way ANOVAs were used to compare multiple means of parametric data and Kruskal–Wallis H-test for non-parametric. A Bonferroni correction was used for multiple comparisons. Mann–Whitney U-test was used to compare specific means with an adjusted p-value according to the number of test performed. Fisher’s exact tests and χ2 analyzed contingency tables of the neuronal response distribution. All statistical analyses were done with SPSS Statistics Version 23 (SAS Institute) or Prism 6.

Results

Post-synaptic activation of ovBNST neurons (0 mV, 100 ms, 2 Hz, 5 min) resulted in robust long-lasting depolarization-induced enhancement of inhibition (l-DEI) in 59% of recorded neurons (time × group, F1,32=7.9, p<0.0001, n=20/34 cells l-DEI from 21 rats; Figure 1a and f). The addition of the v-ATPase inhibitor concanamycin A (5 μM) to the intracellular recording solution completely ablated ovBNST l-DEI that was thus vesicular release-dependent (Fisher’s exact test (NS-aCSF vs NS-Conc), p=0.04, n=0/4 cells l-DEI from 2 rats; Figure 1b and f). In addition, rat strain and light cycle had no effect on l-DEI cell response (χX2(2,n=34)=4.69, p=0.1; Supplementary Table S2).

Figure 1.

Figure 1

Open in a new tab

Effect of post-synaptic depolarization on GABAA synaptic transmission in the ovBNST of non-stressed (NS) rats. Effect of post-synaptic activation on the amplitude of electrically evoked GABAA-IPSCs over time in the ovBNST of NS rats in (a) aCSF, (b) with intracellular concanamycin (5 μM), (c) with extracellular SR-142948 (10 μM), (d) with extracellular NBI-27914, and (e) with extracellular NBI-27914 (1 μM) and SR-142948 (10 μM). Insets in a–e show representative ovBNST GABAA-IPSCs before and after post-synaptic activation followed by the proportion of responding neurons. Scale bar: 250 pA and 25 ms. Double arrows represent post-synaptic depolarization (0 mV, 100 ms at 2 Hz, 5 min). (f) Histogram summarizing the proportion of responding neurons to post-synaptic depolarization across different pharmacological treatments. *p<0.05.

The ovBNST is exclusively populated with GABA neurons that also contain the neuropeptides NT, CRF, dynorphin, or enkephalin (Day et al, 1999; Ju et al, 1989b; Poulin et al, 2009). NT and CRF both increase ovBNST GABAA-IPSCs through either NTR or CRF receptor 1 (CRFR1), respectively, and we hypothesized that one or both could be responsible for l-DEI (Kash and Winder, 2006; Krawczyk et al, 2013). As such we used a non-selective NTR antagonist (SR-142948, 10 μM) and a CRFR1 selective antagonist (NBI-27914, 1 μM). Blocking NTR did not significantly block l-DEI (Fisher’s exact test (NS-aCSF vs NS-SR), p=0.1, n=6/18 cells l-DEI from 11 rats; Figure 1c and f). Likewise, l-DEI was unaltered (56% of neurons) by the CRF antagonist (Fisher’s exact test (NS-aCSF vs NS-NBI), p=1.0, n=5/9 cells l-DEI from 6 rats; Figure 1d and f). However, co-application of SR-142948 and NBI-27914 completely eliminated l-DEI indicating cooperation between NT and CRF in producing l-DEI, which is consistent with their colocalization in ovBNST neurons (Fisher’s exact test (NS-aCSF vs NS-SR/NBI), p=0.004, n=0/8 cells l-DEI from 4 rats; Figure 1e and f) (Ju and Han, 1989a). Interestingly, bath application of NTR antagonist but not of CRFR1 antagonist resulted in a reversible depression of GABAA-IPSCs suggesting constitutive NTR activity (Supplementary Figure S2). In addition, neither NT bath application or repetitive depolarization changed holding current or input resistance indicating membrane potential and channels were not changed by the neuropeptide (Supplementary Table S3).

We next determined whether l-DEI might be altered in the ovBNST of chronically stressed rats. CUS significantly facilitated l-DEI (time, F1,10=5.0, p=0.009, n=11/11 cells l-DEI from 7 animals; Figure 2a) that was now measurable in all tested neurons compared to the NS group (χ2(1,n=45)=6.6, p=0.01; Figure 2e). The NTR antagonist significantly reversed CUS-induced facilitation of l-DEI suggesting that NT took over modulation of ovBNST inhibitory synaptic transmission in stressed conditions (Fisher’s exact test (CUS-aCSF vs CUS-SR), p=0.0002, n=2/10 cells l-DEI from 4 rats; Figure 2b and e). In contrast, CRFR1 blockade had no effect on l-DEI in CUS rats (Fisher’s exact test (CUS-aCSF vs CUS-NBI), p=1.0, n=11/12 cells l-DEI from 3 rats; Figure 2c and e) although both CRF and NT antagonists were necessary to completely eliminate l-DEI (Fisher’s exact test (CUS-aCSF vs CUS-SR/NBI), p=0.0001, n=0/8 cells l-DEI from 5 rats; Figure 2d and e).

Figure 2.

Figure 2

Open in a new tab

Effect of post-synaptic depolarization on GABAA synaptic transmission in the ovBNST of chronic unpredictable stress (CUS)-exposed rats. Effect of post-synaptic activation on the amplitude of electrically evoked GABAA-IPSCs over time in the ovBNST of CUS rats in (a) aCSF, (b) with extracellular SR-142948 (10 μM), (c) with extracellular NBI-27914 (1 μM), and (d) with extracellular NBI-27914 (1 μM) and SR-142948 (10 μM). Insets in a–d show representative ovBNST-evoked GABAA-IPSCs before and after post-synaptic activation followed by the proportion of responding neurons. Scale bar: 250 pA and 25 ms. Double arrows represent post-synaptic depolarization (0 mV, 100 ms at 2 Hz, 5 min). (e) Histogram summarizing the proportion of responding neurons to post-synaptic depolarization across different pharmacological treatments. (f, g) Histogram showing fold change in mRNA expression of Crhr1, Crhr2, Crh, Ntsr1, Ntsr2, and Nts in CUS compared to NS rats in the dBNST and CeA. *p<0.05.

We then investigated changes in mRNA expression of CRF, NT, and their receptors in the dBNST and, the CeA that has strong inhibitory inputs onto the ovBNST and a similar neuropeptide array (expressing both CRF and NT) (Day et al, 1999). In support of CUS-induced changes in the NT system, CUS significantly and selectively reduced dBNST Ntsr1 mRNA levels compared to NS (p=0.05; Figure 2f). In contrast, CUS had no significant effect on other stress-related transcripts in either the dBNST or the CeA (Figure 2f and g).

In NS animals, post-synaptic depolarization resulted in long-lasting depolarization-induced reduction of excitatory synaptic transmission (l-DRE) in all tested neurons (time, F1,7=12.2, p<0.0001, n=9/9 cells l-DRE from 6 rats; Figure 3a and c). The broad-spectrum opioid receptor antagonist Nal (10 μM) abolished l-DRE suggesting that post-synaptic depolarization triggered the local release of endogenous opioids (Fisher’s exact test (NS-aCSF vs NS-Nal), p=0.002, n=2/9 cells l-DRE from 4 rats; Figure 3b and c). The effect of post-synaptic activity on excitatory transmission was largely unaffected by CUS and still resulted in robust l-DRE in the vast majority of recorded ovBNST neurons (time, F1,5=4.2, p=0.05, n=6/7 cells l-DRE from 3 rats; Fisher’s exact test (NS vs CUS), p=0.4; Figure 4a and c). Similar to NS conditions, Nal completely blocked l-DRE (Figure 4b), supporting the involvement of locally released endogenous opioids in this response (Fisher’s exact test (CUS-aCSF vs CUS-Nal), p=0.005, n=0/6 cells l-DRE from 3 rats; Figure 4c).

Figure 3.

Figure 3

Open in a new tab

Effect of post-synaptic depolarization on AMPA synaptic transmission in the ovBNST of NS rats. Effect of post-synaptic activation on the amplitude of electrically evoked AMPA-EPSCs over time in the ovBNST of NS rats in (a) aCSF and (b) with extracellular naloxone (1 μM). Insets in (a and b) show representative ovBNST-evoked AMPA-EPSCs before and after post-synaptic activation followed by the proportion of responding neurons. Scale bar: 250 pA and 25 ms. Double arrows represent post-synaptic depolarization (0 mV, 100 ms at 2 Hz, 5 min). (c) Histogram summarizing the proportion of responding neurons to post-synaptic depolarization across different pharmacological treatments. *p<0.05.

Figure 4.

Figure 4

Open in a new tab

Effect of post-synaptic depolarization on AMPA synaptic transmission in the ovBNST of CUS rats. Effect of post-synaptic activation on the amplitude of electrically evoked AMPA-EPSCs over time in the ovBNST of CUS rats in (a) aCSF and (b) with extracellular naloxone (1 μM). Insets in (a and b) show representative ovBNST-evoked AMPA-EPSCs before and after post-synaptic activation followed by the proportion of responding neurons. Scale bar: 250 pA and 25 ms. Double arrows represent post-synaptic depolarization (0 mV, 100 ms at 2 Hz, 5 min). (c) Histogram summarizing the proportion of responding neurons to post-synaptic depolarization across different pharmacological treatments. *p<0.05.

CUS increases avoidance of open arms in the EPM and immobilization in the FST (Bessa et al, 2009). Converging evidence suggests that the BNST has a key role in these chronic stress-induced anxiety- and depression-like phenomena (Daniel and Rainnie, 2016). As CUS altered the neuromodulatory effect of NT in the ovBNST, we hypothesized that in vivo pharmacological blockade of ovBNST NTR might reverse CUS-induced avoidance of open arms in the EPM and immobility in the FST. As expected, CUS significantly reduced the percentage of time spent in the open arms in saline-treated rats (U=5, p=0.0002; Figure 5d). Intra-ovBNST SR-142948 (5–10 μM/side) had no effect on EPM behaviors in NS but significantly increased the percentage of time spent in the open arms in CUS (Kruskal–Wallis H-test, χ25=18.2, p=0.003; Figure 5d). SR-142948 (5–10 μM/side) dose-dependently reversed this effect in CUS rats (U=7, p=0.0001; Figure 5d). SR-142948 had no effect on the number of open arms entries (Kruskal–Wallis H-test, χ25=5.3, p=0.4; Figure 5e) and did not affect total distance traveled in the OF (F(3,32)=0.7, p=0.6; Supplementary Figure S3) therefore did not affect locomotion. In our conditions, intra-ovBNST NTRs blockade had no effect on immobility scores in the FST in either NS or CUS conditions (Kruskal–Wallis H-test, χ25=8.6, p=0.1; Figure 5f).

Figure 5.

Figure 5

Open in a new tab

Effect of intra-ovBNST NTR pharmacological blockade on elevated plus maze (EPM) and forced swim test (FST) behaviors in NS and CUS rats. (a) Experimental timeline. (b) Photomicrograph showing a representative accurate bilateral cannula placement. (c) Drawing showing all intracranial cannula placements. (d) Bar graph representing the percentage of time spent in the EPM open arms (OA) across experimental groups. (e) Bar graph representing the number of OA entry across experimental groups. (f) Bar graph representing immobility scores in the FST across experimental groups. Accl./Surg., acclimatation/surgeries; Hist, histology; Sal, saline; SR5, SR 142948 (5 μM); SR 10, SR-142948 (10 μM). *p<0.05.

Discussion

We used brain slice whole-cell voltage-clamp recordings and discovered that in the ovBNST of NS rats, post-synaptic activation resulted in long-lasting depolarization-induced enhancement of inhibitory GABAA and reduction of excitatory AMPA synaptic transmission that we termed l-DEI and l-DRE, respectively. NT and CRF both produced l-DEI while opioids were fully responsible for l-DRE. CUS facilitated l-DEI through an enhanced contribution of NT, whereas l-DRE was not affected. Pharmacological blockade of ovBNST NTRs abolished CUS-induced reduction in open arm avoidance in the EPM, suggesting that NT may contribute to anxiety disorders (Laszlo et al, 2010; Saiz Ruiz et al, 1992).

In NS rats, post-synaptic activation produced l-DEI in slightly over half (59%) of recorded ovBNST neurons. There is clear evidence of various ovBNST neuron subpopulations with distinct morphological, neurochemical, or electrophysiological signatures that could explain this dichotomy (Day et al, 1999; Hammack et al, 2007; Ju et al, 1989b; Larriva-Sahd, 2006; Poulin et al, 2009). The neuron-specific expression of l-DEI may be tightly linked with specific neuropeptidergic profiles (Iremonger and Bains, 2009; Ludwig and Pittman, 2003). NT and CRF are highly concentrated in ovBNST neurons and both neuropeptides robustly potentiate GABAA-mediated synaptic transmission although through distinct pre- and post-synaptic loci, respectively (Day et al, 1999; Ju and Han, 1989a; Kash and Winder, 2006; Krawczyk et al, 2013). A study combining brain slice electrophysiology and single-cell PCR showed that 60% of ovBNST neurons contain CRF, which is precisely the percentage of l-DEI response we obtained, supporting a role for CRF in l-DEI (Dabrowska et al, 2011). Importantly, CRF and NT colocalize in the ovBNST, and pharmacological blockade of both CRFR1 and NTR was necessary to completely abolish l-DEI (Ju and Han, 1989a). Application of either neuropeptide antagonist alone did not block l-DEI suggesting a cooperative mechanism, where one neuropeptide activity can compensate for the blockage of the other. The exact functional link however remains elusive.

Post-synaptic activation also resulted in opioid-dependent l-DRE in all recorded ovBNST neurons in NS rats, mitigating the possibility of subpopulation effects. Only 41% of ovBNST neurons seem to express detectable amounts of enkephalins mRNA, which poorly colocalizes with CRF or NT (Day et al, 1999). Dynorphin is also abundant in the rat ovBNST and may have contributed to the opioid-dependent l-DRE we measured (Poulin et al, 2009). Enkephalin and dynorphin are potent inhibitors of excitatory synaptic transmission in the brain, supporting opioid-dependent l-DRE (Crowley et al, 2016). Opioid neuropeptides also modulate inhibitory transmission but we did not detect this response likely due to their short-lasting effects that we did not include in our analyses (Crowley et al, 2016; Dumont and Williams, 2004).

Altogether, our data show that blocking CRFR1, NTR, and opioid receptors completely abolished post-synaptic activation-induced modulation of synaptic transmission in the rat ovBNST. This does not preclude that other stimulation patterns may trigger local synthesis and/or release of other neuromodulators (Puente et al, 2010) or of other neuropeptides expressed in ovBNST neurons (Woodhams et al, 1983). In addition, we focused on long-lasting changes in synaptic transmission but short-duration phenomena have also been reported (Puente et al, 2010). Unquestionably, numerous other neuropeptides, monoamines, or other molecules originating outside the ovBNST also robustly modulate synaptic transmission in this area (Dumont and Williams, 2004; Kash and Winder, 2006; Krawczyk et al, 2013; Krawczyk et al, 2011b; Li et al, 2012; McElligott and Winder, 2008; Shields et al, 2009). Nevertheless, the objective of this study was to determine whether local neuropeptidergic synaptic modulation was affected by chronic stress.

The neurophysiological mechanisms responsible for chronic stress-induced increase in anxiety-like behaviors are still largely unknown. Here CUS-facilitated l-DEI and NT was responsible for this effect, whereas the contribution of CRF was mitigated by stress. This is a novel observation considering that NT has been largely overlooked as a potential contributor in the pathological consequences of stress, compared to CRF (Saiz Ruiz et al, 1992). Alteration of NT function could be due to an increase in NT synthesis, release or receptor membrane expression, binding, or coupling. Under normal physiological conditions, NT increases inhibitory transmission by binding pre-synaptically to NTRs in the ovBNST (Krawczyk et al, 2013). NT increases excitability and firing rate in other brains areas but we did not detect post-synaptic changes in the membrane potential or membrane channels opening suggesting these were not altered in the ovBNST (Jassar et al, 1999; Xiao et al, 2014). Interestingly, the NTR antagonist reversibly depressed GABAA-IPSC amplitude, in a seemingly inverse agonist way. The NTR2 exhibits constitutive activity on inositol phosphate production (Richard et al, 2001). Thus, the inverse agonist activity could occur through NTR2s that are also highly expressed in the BNST GABA neurons (Mazzone et al, 2016). However, it is still unknown whether the l-DEI is specific to or a combination of NTR1 and NTR2 activity and whether this is altered with CUS.

When we investigated mRNA expression, only Ntsr1 mRNA, and not Nts or Ntsr2, was decreased in CUS rats compared to NS. Our findings corroborate other studies showing reduction of Ntsr1 mRNA following maternal separation or CRF-overexpressing mice (Peeters et al, 2004; Toda et al, 2014). CUS decreasing Ntsr1 mRNA expression may not result in a reduction of the NTR1 receptor expression at the cellular membrane. A decrease in Ntsr1 mRNA could be due to an increase in mRNA stability or a compensatory mechanism to reduce increased NT activity. The latter explanation could indicate that NTR1 expression is actually increased with CUS and may be responsible for the changes in cell responses. Future studies investigating protein level expression is necessary to fully understand the neurophysiological changes occurring with CUS.

The CUS paradigm in this study utilizes variable and uncontrollable stress, where the animal does not habituate to the repeated stressors over time (Herman, 2013). As predicted from previous studies, we found that rats that underwent the CUS paradigm spent significantly less time in the open arms compared to their NS counterparts. Whether this behavior is ‘adaptive’ or ‘maladaptive’ is unclear. In the context of our EPM test, chronically stressed animals could be mounting an adaptive response to a reasonably imminent threat. Alternatively, their response could be interpreted as maladaptive as the animal limits their exploration and possibility of finding resources in the absence of an immediate threat. As the rats had no controllability over the stressors, it is impossible to distinguish whether they were mounting a contextually appropriate or inappropriate response.

Intra-ovBNST microinjections of a NTR antagonist did however robustly modify CUS rats behaviors in the EPM, tying the sensitized NT neurophysiological response in ovBNST neurons of stressed rats with their anxiety profile. NTR blockade reversed the anxiogenic effect of CUS without affecting normal EPM exploratory behavior displayed by NS rats. This is consistent with the fact that NT seems particularly important in mounting physiological and behavioral responses to face potentially extreme conditions (eg, store fat, seek rich and highly rewarding nutrients, and increase vigilance) (Deutch et al, 1987; Geisler et al, 2006; Krawczyk et al, 2013; Li et al, 2016; Luttinger et al, 1982). We also tested the effect of CUS on immobility in the FST but we did not find any changes in behavior previously reported (Bessa et al, 2009). This discrepancy may be due to the shorter duration of the stress paradigm although our data showed that NT in the ovBNST may not contribute to this behavior, regardless of the stress condition (Crestani et al, 2010).

Overall, these findings elucidate a clear role for NT in chronic stress although we cannot conclude exactly how NT-induced increase of GABA transmission in the ovBNST translates into anxiety-like behavior in the EPM. However, anatomical studies enable us to speculate how a NT-induced decrease of ovBNST activity could affect the HPA axis. The ovBNST has strong GABAergic outputs onto the fusiform nucleus of the BNST (fuBNST) that has direct inhibitory inputs onto the paraventricular nucleus of the hypothalamus (Dong et al, 2001). Lesion of the fuBNST attenuates HPA axis response suggesting it enhances PVN activity (Choi et al, 2007). As such, a NT-mediated reduction of ovBNST inhibition output to the fuBNST could promote HPA axis excitation and result in a decrease of EPM open arm exploration. Parallel to this, in the PVN, blocking NTR during stress counteracts the increase of plasma corticosterone levels (Geisler et al, 2006). In addition, decrease activity in ovBNST inhibitory projections could increase fear/anxiety (CeA), vigilance and arousal (substantia innominata), respiration (parabrachial nucleus), and defensive response (periaqueductal gray) (Dong et al, 2001). At this point however, we cannot discern the exact output of the ovBNST and whether it is affecting local or extrinsic circuitry.

The NT system in different brain areas could be working in concert to stimulate the HPA axis during stress conditions. Future studies should explore whether the magnitude of NT activation of the HPA axis could possibly correlate with maladaptive vs adaptive behavior.

Funding and disclosure

The authors declare no conflict of interest.

Acknowledgments

CPN was funded by CIHR Vanier Graduate Scholarship (338319); APVS was funded by Fundação para a Ciência e Tecnologia (SFRH/BPD/52078/2013); ERH was funded by CIHR Postdoctoral Fellowship (MFE-123712); SA was funded by a Queen Elizabeth II Graduate Scholarship in Science and Technology; ÉCD was funded by the Canadian Institute of Health Research (MOP-25953).

Footnotes

Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)

Supplementary Material

Supplementary Tables
Click here for additional data file. (104.3KB, docx)
Supplementary Figure S1
Click here for additional data file. (54.5MB, pdf)
Supplementary Figure S2
Click here for additional data file. (360.2KB, pdf)
Supplementary Figure S3
Click here for additional data file. (302.4KB, pdf)

References

  1. Bessa JM, Mesquita AR, Oliveira M, Pego JM, Cerqueira JJ, Palha JA et al (2009). A trans-dimensional approach to the behavioral aspects of depression. Front Behav Neurosci 3: 1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Binder EB, Kinkead B, Owens MJ, Nemeroff CB (2001). Neurotensin and dopamine interactions. Pharmacol Rev 53: 453–486. [PubMed] [Google Scholar]
  3. Cerqueira JJ, Mailliet F, Almeida OF, Jay TM, Sousa N (2007). The prefrontal cortex as a key target of the maladaptive response to stress. J Neurosci 27: 2781–2787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Choi DC, Furay AR, Evanson NK, Ostrander MM, Ulrich-Lai YM, Herman JP (2007). Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs. J Neurosci 27: 2025–2034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Conrad KL, Louderback KM, Gessner CP, Winder DG (2011). Stress-induced alterations in anxiety-like behavior and adaptations in plasticity in the bed nucleus of the stria terminalis. Physiol Behav 104: 248–256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Crestani CC, Alves FH, Correa FM, Guimaraes FS, Joca SR (2010). Acute reversible inactivation of the bed nucleus of stria terminalis induces antidepressant-like effect in the rat forced swimming test. Behav Brain Funct 6: 30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Crowley NA, Bloodgood DW, Hardaway JA, Kendra AM, McCall JG, Al-Hasani R et al (2016). Dynorphin controls the gain of an amygdalar anxiety circuit. Cell Rep 14: 2774–2783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dabrowska J, Hazra R, Ahern TH, Guo JD, McDonald AJ, Mascagni F et al (2011). Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: Implications for balancing stress and affect. Psychoneuroendocrinology 36: 1312–1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dabrowska J, Hazra R, Guo JD, Li C, Dewitt S, Xu J et al (2013). Striatal-enriched protein tyrosine phosphatase-STEPs toward understanding chronic stress-induced activation of corticotrophin releasing factor neurons in the rat bed nucleus of the stria terminalis. Biol Psychiatry 74: 817–826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Daniel SE, Rainnie DG (2016). Stress modulation of opposing circuits in the bed nucleus of the stria terminalis. Neuropsychopharmacology 41: 103–125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Day HE, Curran EJ, Watson SJ Jr., Akil H (1999). Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta. J Comp Neurol 413: 113–128. [PubMed] [Google Scholar]
  12. Deppermann S, Storchak H, Fallgatter AJ, Ehlis AC (2014). Stress-induced neuroplasticity: (mal)adaptation to adverse life events in patients with PTSD—a critical overview. Neuroscience 283: 166–177. [DOI] [PubMed] [Google Scholar]
  13. Deutch AY, Bean AJ, Bissette G, Nemeroff CB, Robbins RJ, Roth RH (1987). Stress-induced alterations in neurotensin, somatostatin and corticotropin-releasing factor in mesotelencephalic dopamine system regions. Brain Res 417: 350–354. [DOI] [PubMed] [Google Scholar]
  14. Dong HW, Petrovich GD, Watts AG, Swanson LW (2001). Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J Comp Neurol 436: 430–455. [DOI] [PubMed] [Google Scholar]
  15. Dumont EC, Williams JT (2004). Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J Neurosci 24: 8198–8204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Geisler S, Berod A, Zahm DS, Rostene W (2006). Brain neurotensin, psychostimulants, and stress—emphasis on neuroanatomical substrates. Peptides 27: 2364–2384. [DOI] [PubMed] [Google Scholar]
  17. Glangetas C, Girard D, Groc L, Marsicano G, Chaouloff F, Georges F (2013). Stress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis. J Neurosci 33: 19657–19663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gosselin P, Laberge B (2003). [Etiological factors of generalized anxiety disorder]. Encephale 29(4 Pt 1): 351–361. [PubMed] [Google Scholar]
  19. Hammack SE, Mania I, Rainnie DG (2007). Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis. J Neurophysiol 98: 638–656. [DOI] [PubMed] [Google Scholar]
  20. Hammen C, Kim EY, Eberhart NK, Brennan PA (2009). Chronic and acute stress and the prediction of major depression in women. Depress Anxiety 26: 718–723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Herman JP (2013). Neural control of chronic stress adaptation. Front Behav Neurosci 7: 61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hubert GW, Muly EC (2014). Distribution of AMPA receptor subunit glur1 in the bed nucleus of the stria terminalis and effect of stress. Synapse 68: 194–201. [DOI] [PubMed] [Google Scholar]
  23. Iremonger KJ, Bains JS (2009). Retrograde opioid signaling regulates glutamatergic transmission in the hypothalamus. J Neurosci 29: 7349–7358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jassar BS, Harris KH, Ostashewski PM, Jhamandas JH (1999). Ionic mechanisms of action of neurotensin in acutely dissociated neurons from the diagonal band of Broca of the rat. J Neurophysiol 81: 234–246. [DOI] [PubMed] [Google Scholar]
  25. Ju G, Han ZS (1989. a). Coexistence of corticotropin releasing factor and neurotensin within oval nucleus neurons in the bed nuclei of the stria terminalis in the rat. Neurosci Lett 99: 246–250. [DOI] [PubMed] [Google Scholar]
  26. Ju G, Swanson LW, Simerly RB (1989. b). Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: II. Chemoarchitecture. J Comp Neurol 280: 603–621. [DOI] [PubMed] [Google Scholar]
  27. Kash TL, Winder DG (2006). Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 51: 1013–1022. [DOI] [PubMed] [Google Scholar]
  28. Kim SY, Adhikari A, Lee SY, Marshel JH, Kim CK, Mallory CS et al (2013). Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature 496: 219–223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Krawczyk M, Georges F, Sharma R, Mason X, Berthet A, Bezard E et al (2011. a). Double-dissociation of the catecholaminergic modulation of synaptic transmission in the oval bed nucleus of the stria terminalis. J Neurophysiol 105: 145–153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Krawczyk M, Mason X, DeBacker J, Sharma R, Normandeau CP, Hawken ER et al (2013). D1 dopamine receptor-mediated LTP at GABA synapses encodes motivation to self-administer cocaine in rats. J Neurosci 33: 11960–11971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Krawczyk M, Sharma R, Mason X, Debacker J, Jones AA, Dumont EC (2011. b). A switch in the neuromodulatory effects of dopamine in the oval bed nucleus of the stria terminalis associated with cocaine self-administration in rats. J Neurosci 31: 8928–8935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Larriva-Sahd J (2006). Histological and cytological study of the bed nuclei of the stria terminalis in adult rat. II. Oval nucleus: extrinsic inputs, cell types, neuropil, and neuronal modules. J Comp Neurol 497: 772–807. [DOI] [PubMed] [Google Scholar]
  33. Laszlo K, Toth K, Kertes E, Peczely L, Ollmann T, Lenard L (2010). Effects of neurotensin in amygdaloid spatial learning mechanisms. Behav Brain Res 210: 280–283. [DOI] [PubMed] [Google Scholar]
  34. Lezak KR, Roman CW, Braas KM, Schutz KC, Falls WA, Schulkin J et al (2014). Regulation of bed nucleus of the stria terminalis PACAP expression by stress and corticosterone. J Mol Neurosci 54: 477–484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Li C, Pleil KE, Stamatakis AM, Busan S, Vong L, Lowell BB et al (2012). Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling. Biol psychiatry 71: 725–732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Li J, Song J, Zaytseva YY, Liu Y, Rychahou P, Jiang K et al (2016). An obligatory role for neurotensin in high-fat-diet-induced obesity. Nature 533: 411–415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Ludwig M, Pittman QJ (2003). Talking back: dendritic neurotransmitter release. Trends Neurosci 26: 255–261. [DOI] [PubMed] [Google Scholar]
  38. Luttinger D, King RA, Sheppard D, Strupp J, Nemeroff CB, Prange AJ Jr. (1982). The effect of neurotensin on food consumption in the rat. Eur J Pharmacol 81: 499–503. [DOI] [PubMed] [Google Scholar]
  39. Mazzone CM, Pati D, Michaelides M, DiBerto J, Fox JH, Tipton G et al (2016). Acute engagement of Gq-mediated signaling in the bed nucleus of the stria terminalis induces anxiety-like behavior. Mol Psychiatry (epub ahead of print). [DOI] [PMC free article] [PubMed]
  40. McElligott ZA, Klug JR, Nobis WP, Patel S, Grueter BA, Kash TL et al (2010). Distinct forms of Gq-receptor-dependent plasticity of excitatory transmission in the BNST are differentially affected by stress. Proc Natl Acad Sci USA 107: 2271–2276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. McElligott ZA, Winder DG (2008). Alpha1-adrenergic receptor-induced heterosynaptic long-term depression in the bed nucleus of the stria terminalis is disrupted in mouse models of affective disorders. Neuropsychopharmacology 33: 2313–2323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Peeters PJ, Fierens FL, van den Wyngaert I, Goehlmann HW, Swagemakers SM, Kass SU et al (2004). Gene expression profiles highlight adaptive brain mechanisms in corticotropin releasing factor overexpressing mice. Brain Res Mol Brain Res 129: 135–150. [DOI] [PubMed] [Google Scholar]
  43. Pego JM, Morgado P, Pinto LG, Cerqueira JJ, Almeida OF, Sousa N (2008). Dissociation of the morphological correlates of stress-induced anxiety and fear. Eur J Neurosci 27: 1503–1516. [DOI] [PubMed] [Google Scholar]
  44. Poulin JF, Arbour D, Laforest S, Drolet G (2009). Neuroanatomical characterization of endogenous opioids in the bed nucleus of the stria terminalis. Prog Neuropsychopharmacol Biol Psychiatry 33: 1356–1365. [DOI] [PubMed] [Google Scholar]
  45. Puente N, Elezgarai I, Lafourcade M, Reguero L, Marsicano G, Georges F et al (2010). Localization and function of the cannabinoid CB1 receptor in the anterolateral bed nucleus of the stria terminalis. PloS one 5: e8869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Richard F, Barroso S, Martinez J, Labbe-Jullie C, Kitabgi P (2001). Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2. Mol Pharmacol 60: 1392–1398. [DOI] [PubMed] [Google Scholar]
  47. Saiz Ruiz J, Carrasco Perera JL, Hernanz A (1992). Plasma neuropeptides in affective and anxiety disorders. Arch Neurobiol (Madr) 55: 1–5. [PubMed] [Google Scholar]
  48. Shields AD, Wang Q, Winder DG (2009). alpha2A-adrenergic receptors heterosynaptically regulate glutamatergic transmission in the bed nucleus of the stria terminalis. Neuroscience 163: 339–351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Toda H, Boku S, Nakagawa S, Inoue T, Kato A, Takamura N et al (2014). Maternal separation enhances conditioned fear and decreases the mRNA levels of the neurotensin receptor 1 gene with hypermethylation of this gene in the rat amygdala. PLoS ONE 9: e97421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Vyas A, Bernal S, Chattarji S (2003). Effects of chronic stress on dendritic arborization in the central and extended amygdala. Brain Res 965: 290–294. [DOI] [PubMed] [Google Scholar]
  51. Walker DL, Miles LA, Davis M (2009). Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Prog Neuropsychopharmacol Biol Psychiatry 33: 1291–1308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Woodhams PL, Roberts GW, Polak JM, Crow TJ (1983). Distribution of neuropeptides in the limbic system of the rat: the bed nucleus of the stria terminalis, septum and preoptic area. Neuroscience 8: 677–703. [DOI] [PubMed] [Google Scholar]
  53. Xiao Z, Cilz NI, Kurada L, Hu B, Yang C, Wada E et al (2014). Activation of neurotensin receptor 1 facilitates neuronal excitability and spatial learning and memory in the entorhinal cortex: beneficial actions in an Alzheimer's disease model. J Neurosci 34: 7027–7042. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Tables
Click here for additional data file. (104.3KB, docx)
Supplementary Figure S1
Click here for additional data file. (54.5MB, pdf)
Supplementary Figure S2
Click here for additional data file. (360.2KB, pdf)
Supplementary Figure S3
Click here for additional data file. (302.4KB, pdf)

Articles from Neuropsychopharmacology are provided here courtesy of Nature Publishing Group

RESOURCES